You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol
|
|---|---|
| Published in |
BMJ Open, January 2018
|
| DOI | 10.1136/bmjopen-2017-019463 |
| Pubmed ID | |
| Authors |
Clara K Chow, Aravinda Thiagalingam, Karla Santo, Cindy Kok, Jay Thakkar, Sandrine Stepien, Laurent Billot, Stephen Jan, Rohina Joshi, Graham S Hillis, David Brieger, Derek P Chew, Karin Rådholm, John J Atherton, Ravinay Bhindi, Nicholas Collins, Steven Coverdale, Christian Hamilton-Craig, Nadarajah Kangaharan, Andrew Maiorana, Michelle McGrady, Pratap Shetty, Peter Thompson, Anthony Rogers, Julie Redfern |
| Abstract |
Identifying simple, low-cost and scalable means of supporting lifestyle change and medication adherence for patients following a cardiovascular (CV) event is important. The TEXTMEDS (TEXT messages to improve MEDication adherence and Secondary prevention) study aims to investigate whether a cardiac education and support programme sent via mobile phone text message improves medication adherence and risk factor levels in patients following an acute coronary syndrome (ACS). A single-blind, multicentre, randomised clinical trial of 1400 patients after an ACS with 12 months follow-up. The intervention group will receive multiple weekly text messages that provide information, motivation, support to adhere to medications, quit smoking (if relevant) and recommendations for healthy diet and exercise. The primary endpoint is the percentage of patients who are adherent to cardioprotective medications and the key secondary outcomes are mean systolic blood pressure (BP) and low-density lipoprotein cholesterol. Secondary outcomes will also include total cholesterol, mean diastolic BP, the percentage of participants who are adherent to each cardioprotective medication class, the percentage of participants who achieve target levels of CV risk factors, major vascular events, hospital readmissions and all-cause mortality. The study will be augmented by formal economic and process evaluations to assess acceptability, utility and cost-effectiveness. The study will provide multicentre randomised trial evidence of the effects of a text message-based programme on cardioprotective medication adherence and levels of CV risk factors. Primary ethics approval was received from Western Sydney Local Health District Human Research Ethics Committee (HREC2012/12/4.1 (3648) AU RED HREC/13/WMEAD/15). Results will be disseminated via peer-reviewed publications and presentations at international conferences. ACTRN12613000793718; Pre-results. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 7 | 70% |
| Unknown | 3 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 50% |
| Scientists | 4 | 40% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 277 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 50 | 18% |
| Student > Ph. D. Student | 27 | 10% |
| Student > Bachelor | 26 | 9% |
| Student > Doctoral Student | 16 | 6% |
| Researcher | 14 | 5% |
| Other | 33 | 12% |
| Unknown | 111 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 54 | 19% |
| Medicine and Dentistry | 50 | 18% |
| Psychology | 12 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
| Agricultural and Biological Sciences | 5 | 2% |
| Other | 26 | 9% |
| Unknown | 124 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#954,829
of 25,382,440 outputs
Outputs from BMJ Open
#1,668
of 25,593 outputs
Outputs of similar age
#22,380
of 449,913 outputs
Outputs of similar age from BMJ Open
#58
of 617 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 25,593 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,913 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 617 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.